Newborn affected by other maternal medication Notes: dysmorphism due to warfarin (Q86.2) ; fetal hydantoin syndrome (Q86.1) ; maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0) ...
P04.42 Newborn affected by maternal use of hallucinogens Notes: newborn affected by other maternal medication (P04.1-)
Newborn affected by maternal use of hallucinogens Notes: newborn affected by other maternal medication (P04.1-)
P00.9 Newborn affected by unspecified maternal condition
Newborn affected by unspecified maternal condition
P02.20 Newborn affected by unspecified morphological and functional abnormalities of placenta
Newborn affected by unspecified morphological and functional abnormalities of placenta
P03.2 Newborn affected by forceps delivery
Newborn affected by forceps delivery
P04.11 Newborn affected by maternal antineoplastic chemotherapy
Newborn affected by maternal antineoplastic chemotherapy
P04.49 Newborn affected by maternal use of other drugs of addiction Notes: newborn affected by maternal anesthesia and analgesi…
Newborn affected by maternal use of other drugs of addiction Notes: newborn affected by maternal anesthesia and analgesia (P04.0) ; withdrawal symptoms from maternal use of drugs of addiction (P96.1)
P01 Newborn affected by maternal complications of pregnancy Notes: Newborn affected by hydramnios ; Newborn affected by abdo…
Newborn affected by maternal complications of pregnancy Notes: Newborn affected by hydramnios ; Newborn affected by abdominal pregnancy ; Newborn affected by triplet (pregnancy) ; Newborn affected by ...
